NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Enter Hollywood

North, South Korean musicians hold rare joint performance

Jun 15, 2019

SHANGHAI — South Korean violinist Won Hyung Joon took the stage, nodded once to his North Korean soprano partner, and placed his instrument on his shoulder. With a flick of the conductor's wrist, she began to sing, and he began to bow — the beginning of a rare joint performance Sunday that they hope will bring the Koreas closer amid deadlocked nuclear diplomacy. "Until today, I was thinking, will this really happen? Will it suddenly be canceled?" Won said. "Today was the day my dream finally came true." Won, donning a white shirt, and Kim Song Mi, sporting a sparkling...

Michael Wolf, photographer of mega-cities, dies in Hong Kong

Jun 15, 2019

HONG KONG — Michael Wolf, an award-winning photographer known for his work depicting megacities, has died at his home in Hong Kong. He was 64. Wolf died in his sleep on Wednesday, said Sarah Greene, an art gallery director who worked closely with him. She did not give a cause of death. Wolf won first prize in the World Press Photo competition twice, for contemporary issues in 2005 and for daily life in 2010. His body of work included Tokyo, Chicago, Paris and Hong Kong, where Wolf moved in 1994. "His main muse was Hong Kong," said Greene, the director...

Artisan keeps his craft alive with each carved mahjong tile

Jun 15, 2019

HONG KONG — Just opposite the entrance to a neon-lit night market, one of Hong Kong's few remaining carvers of mahjong tiles engraves the two Chinese characters for the number 8,000 on a piece of acrylic. With a knife in his right hand, Cheung Shun-king turns the tile with the other to cut into it. From time to time, he gently blows away the shavings. His is a dying craft in an era of mass-produced tiles for the table-top game, popular in southern China, Hong Kong and Taiwan. The 65-year-old artisan believes there are only three or four carvers left...

Fed Cup semi: Australia, Belarus tied 2-2 ahead of doubles

Jun 15, 2019

BRISBANE, Australia — The Fed Cup semifinal between Australia and Belarus is going to a doubles decider. Victoria Azarenka beat Australia's Sam Stosur in the second reverse singles Sunday 6-1, 6-1 in 59 minutes to even the match at 2-2 on hard courts at Pat Rafter Arena. In the second set, Azarenka went ahead 3-1 when Stosur double-faulted to set up break point. Azarenka's win was met with loud cheers from the small but noisy group of Belarusian fans waving their country's red and green flag. In the deciding doubles, Ashleigh Barty and Stosur were expected to play Vera Lapko...

Fed Cup semifinal: Australia, Belarus level after 1st day

Jun 15, 2019

BRISBANE, Australia — Australian Ashleigh Barty beat doubles partner Victoria Azarenka of Belarus 7-6 (2), 6-3 to level their Fed Cup semifinal at 1-1 on Saturday. Barty's win on hard courts at Pat Rafter Arena ended Azarenka's 13-match winning streak in the Fed Cup. "I knew the first set would be key," Barty said after the opening day of singles. "It was just about me coming out and doing everything right. I prepared really well all week. This is why we train, we want to get down to crunch time, go out and enjoy it." Earlier, Aryna Sabalenka gave Belarus...

Sign up now!